Zsolt Harsanyi's most recent trade in Emergent Biosolutions Inc was a trade of 34,403 Common Stock done . Disclosure was reported to the exchange on April 30, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc | Zsolt Harsanyi | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 34,403 | 123,732 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 15,824 | 41,572 | - | - | Stock Option (Right to Buy) | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 280 (0%) | 0% | - | Common Stock | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 199 (0%) | 0% | - | Common Stock | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 25,748 | 25,748 | - | - | Stock Option (Right to Buy) | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 17,430 | 89,329 (0%) | 0% | 0 | Common Stock | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 8,475 (0%) | 0% | - | Common Stock | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 4,904 (0%) | 0% | - | Common Stock | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director, Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 33,847 | 71,899 (0%) | 0% | 0 | Common Stock | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 595 | - | - | Restricted Stock Unit | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 4,607 (0%) | 0% | - | Common Stock | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 8,446 | 38,052 (0%) | 0% | 0 | Common Stock | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 5,027 | 29,606 (0%) | 0% | 0 | Common Stock | |
Emergent Biosolutions Inc | Zsolt Harsanyi | Director | Sale of securities on an exchange or to another person at price $ 133.71 per share. | 17 Aug 2020 | 6,609 | 24,579 (0%) | 0% | 133.7 | 883,664 | Common Stock |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
Aptevo Therapeutics Inc | Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) |